Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Augmentation with Cariprazine for Treatment-Resistant Depression

Practical Implementation

  • The American College of Physicians recommends continuing mirtazapine at the current dose of 45mg QHS, as this is within the effective therapeutic range, when augmenting with cariprazine 1

Alternative Considerations

  • The American Gastroenterological Association suggests that atypical antipsychotics like quetiapine or olanzapine are alternatives for augmentation, but should be reserved for cases with significant psychiatric comorbidity or after psychiatric consultation, per guidelines addressing chronic pain and depression 2

REFERENCES

1

Mirtazapine's Appetite-Stimulating Effects [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025